Business, energy, technology, markets and global industry news from Business News Today

Prix Galien USA

PharmaDeviceNews Prix Galien USA
Ingenia Therapeutics’ dual Prix Galien USA and Korea nominations add visibility to the newly listed biotech as attention turns to its TIE2-based vascular therapeutics pipeline, including MK-8748 and IGT-303. Representative image.
Pharma & Biotech

Ingenia Therapeutics has two Prix Galien nominations, but its real test begins after the KOSDAQ IPO

Ingenia Therapeutics gains dual Prix Galien nominations as its KOSDAQ debut puts MK-8748, IGT-303 and the broader TIE2 pipeline under scrutiny.

Read More
Innoviva’s XACDURO, ZEVTERA and NUZOLVENCE highlight the company’s expanding antimicrobial portfolio after all three therapies were named finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award. Representative image.
Pharma & Biotech

Three antibiotics, three different AMR battles: why Innoviva’s Prix Galien triple could matter beyond the awards

Innoviva’s XACDURO, ZEVTERA and NUZOLVENCE reach the 2026 Prix Galien finals, spotlighting a growing anti-infective portfolio.

Read More